-
1
-
-
33645545779
-
Psoriasis treatment in the United States at the end of the 20th century
-
Pearce DJ, Stealey KH, Balkrishnan R, et al. Psoriasis treatment in the United States at the end of the 20th century. Int J Dematol. 2006;45:370-374.
-
(2006)
Int J Dematol
, vol.45
, pp. 370-374
-
-
Pearce, D.J.1
Stealey, K.H.2
Balkrishnan, R.3
-
2
-
-
0034805313
-
Treatment of psoriasis, part 1. topical therapy and phototherapy
-
Lebwohl M, Ali S. Treatment of psoriasis, part 1. topical therapy and phototherapy. J Am Acad Dermatol. 2001;45:487-498.
-
(2001)
J Am Acad Dermatol
, vol.45
, pp. 487-498
-
-
Lebwohl, M.1
Ali, S.2
-
3
-
-
0038163576
-
The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions
-
Gottlieb AB, Ford RO, Spellman MC. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions. J Cutan Med Surg. 2003;7:185-192.
-
(2003)
J Cutan Med Surg
, vol.7
, pp. 185-192
-
-
Gottlieb, A.B.1
Ford, R.O.2
Spellman, M.C.3
-
4
-
-
4944234454
-
Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis
-
Decroix J, Pres H, Tsankov N, et al. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis. Cutis. 2004;74:201-206.
-
(2004)
Cutis
, vol.74
, pp. 201-206
-
-
Decroix, J.1
Pres, H.2
Tsankov, N.3
-
5
-
-
0025724093
-
-
Goldberg B, Hartdegen R, Presbury D, et al. A double-blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasis. J Am Acad Dermatol. 1991;25 (6pt2):1145-1148.
-
Goldberg B, Hartdegen R, Presbury D, et al. A double-blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasis. J Am Acad Dermatol. 1991;25 (6pt2):1145-1148.
-
-
-
-
6
-
-
0037420518
-
Psoriasis
-
Lebwohl M. Psoriasis. Lancet. 2003;361:1197-1204.
-
(2003)
Lancet
, vol.361
, pp. 1197-1204
-
-
Lebwohl, M.1
-
7
-
-
0037976822
-
A host of novel agents for treating psoriasis, psoriatic arthritis stir interest
-
2783
-
Lamberg L. A host of novel agents for treating psoriasis, psoriatic arthritis stir interest. JAMA. 2003;289: 2779-2780, 2783.
-
(2003)
JAMA
, vol.289
, pp. 2779-2780
-
-
Lamberg, L.1
-
8
-
-
0043134974
-
New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: A personal appraisal of their use in practice
-
Callen JP. New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: a personal appraisal of their use in practice. J Am Acad Dermatol. 2003;49: 351-356.
-
(2003)
J Am Acad Dermatol
, vol.49
, pp. 351-356
-
-
Callen, J.P.1
-
9
-
-
15744398663
-
Combining traditional agents and biologies for the treatment of psoriasis
-
Cather JC, Menter A. Combining traditional agents and biologies for the treatment of psoriasis. Semin Cutan Med Surg. 2005;24:37-45.
-
(2005)
Semin Cutan Med Surg
, vol.24
, pp. 37-45
-
-
Cather, J.C.1
Menter, A.2
-
10
-
-
1542344331
-
Combination therapy to treat moderate to severe psoriasis
-
Lebwohl M, Menter A, Koo J, et al. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50:416-430.
-
(2004)
J Am Acad Dermatol
, vol.50
, pp. 416-430
-
-
Lebwohl, M.1
Menter, A.2
Koo, J.3
-
11
-
-
33748923950
-
A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: Short- and long-term outcomes
-
Koo J, Blum RR, Lebwohl M. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. J Am Acad Dermatol. 2006;55:637-641.
-
(2006)
J Am Acad Dermatol
, vol.55
, pp. 637-641
-
-
Koo, J.1
Blum, R.R.2
Lebwohl, M.3
-
12
-
-
0030862124
-
Topical application of calcipotriene and corticosteroids: Combination regimens
-
Lebwohl M. Topical application of calcipotriene and corticosteroids: combination regimens. J Am Acad Dermatol. 1997;37(3 pt 2):S55-S58.
-
(1997)
J Am Acad Dermatol
, vol.37
, Issue.3 PART 2
-
-
Lebwohl, M.1
-
13
-
-
33748911090
-
An intraindividual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis
-
Beutner K, Chakrabarty A, Lemke S, et al. An intraindividual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis. J Drugs Dermatol. 2006;5:357-360.
-
(2006)
J Drugs Dermatol
, vol.5
, pp. 357-360
-
-
Beutner, K.1
Chakrabarty, A.2
Lemke, S.3
-
14
-
-
33845655894
-
Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis
-
Jarratt MT, Clark SD, Savin RC, et al. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis. Cutis. 2006;78: 348-354.
-
(2006)
Cutis
, vol.78
, pp. 348-354
-
-
Jarratt, M.T.1
Clark, S.D.2
Savin, R.C.3
-
15
-
-
37049026657
-
Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial
-
Menter A. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial. Cutis. 2007;80(suppl 5):12-19.
-
(2007)
Cutis
, vol.80
, Issue.SUPPL. 5
, pp. 12-19
-
-
Menter, A.1
-
16
-
-
37049034051
-
Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: Add-on therapy in the COBRA trial
-
Feldman SR. Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial. Cutis. 2007;80(suppl 5): 20-28.
-
(2007)
Cutis
, vol.80
, Issue.SUPPL. 5
, pp. 20-28
-
-
Feldman, S.R.1
-
17
-
-
0028332995
-
Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use
-
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.
-
(1994)
Clin Exp Dermatol
, vol.19
, pp. 210-216
-
-
Finlay, A.Y.1
Khan, G.K.2
-
18
-
-
20444466784
-
Decision points for the initiation of systemic treatment for psoriasis
-
Feldman SR, Koo JY, Menter A, et al. Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol. 2005;53:101-107.
-
(2005)
J Am Acad Dermatol
, vol.53
, pp. 101-107
-
-
Feldman, S.R.1
Koo, J.Y.2
Menter, A.3
|